ChiCTR1900023440
尚未开始
/
/
/
2019-05-27
/
/
小腦共濟失調
Medical and non-medical expense following cerebellar ataxia
Disease burden of cerebellar ataxia in Hong Kong: A retrospective cost-utility analysis.
(1) to estimate the direct and indirect social economic costs; (2) to assess the health-related quality of life (HRQOL) in patients with cerebellar ataxia during 2019 in Hong Kong; (3a) to examine the correlation between the severity of cerebellar ataxia and cost, and; (3b) to examine the correlation between severity of cerebellar ataxia and quality of life.
队列研究
回顾性研究
Not applicable for this study design
N/A
HKPOLYU and HKSCAA
/
100
/
2019-02-01
2019-12-31
/
Participants will be included if they have a confirmed diagnosis of cerebellar ataxia of any cause；
登录查看Volunteers will be excluded if they present with severe cognitive problems or unwilling to reveal personal information.；
登录查看香港理工大學
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
